Literature DB >> 23479431

Morphological spectrum and clinical features of myopathies with tubular aggregates.

Fabian Funk1, Chantal Ceuterick-de Groote, Jean-Jacques Martin, Axel Meinhardt, Ana L Taratuto, Jan De Bleecker, Rudy Van Coster, Boel De Paepe, Ulrike Schara, Matthias Vorgerd, Martin Häusler, Stefan Koppi, Matthias Maschke, Peter De Jonghe, Lionel Van Maldergem, Stéphane Noel, Christoph W Zimmermann, Stefan Wirth, Stefan Isenmann, Rudolf Stadler, J Michael Schröder, Jörg B Schulz, Joachim Weis, Kristl G Claeys.   

Abstract

Tubular aggregates (TAs) are aggregates of densely packed tubules in human skeletal muscle fibers with particular histochemical and ultrastructural features that most probably arise from the sarcoplasmic reticulum. Some studies have shown an additional mitochondrial origin of TAs. We studied the histopathological spectrum and clinical features in a large cohort of patients with TAs in their muscle biopsy (106 biopsies), derived from our muscle biopsy archive (15,412 biopsies in total). In particular, we examined light microscopic, enzyme histochemical, immunohistochemical and ultrastructural features in the muscle biopsies, as well as the patients' clinical data. We found TAs in 0.5% of all muscle biopsies. Based on the size of TAs, we identified two sub-groups: (1) myopathies with large TAs (29 biopsies) in type 2 fibers and sometimes also in type 1 fibers, absence of any other associated disorder, and a familial history in half of the cases, and (2) myopathies with small TAs (77 biopsies), exclusively in type 2 fibers, presence of another associated disease in the majority of patients and mostly no familial history. In the sub-group with large TAs, we observed a high variability of ultrastructural changes. The most frequent clinical symptom in both groups was limb muscle weakness. No significant differences in clinical presentation, age at onset or disease duration at the time of biopsy were found between the two groups. In conclusion, myopathies with TAs can be sub-divided into a group with large TAs, probably corresponding to the so-called primary TA myopathies, and into a group with small TAs as a feature of another underlying condition.

Entities:  

Mesh:

Year:  2013        PMID: 23479431     DOI: 10.14670/HH-28.1041

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  7 in total

1.  Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin.

Authors:  Xingxing Kong; Ting Yao; Peng Zhou; Lawrence Kazak; Danielle Tenen; Anna Lyubetskaya; Brian A Dawes; Linus Tsai; Barbara B Kahn; Bruce M Spiegelman; Tiemin Liu; Evan D Rosen
Journal:  Cell Metab       Date:  2018-08-02       Impact factor: 27.287

2.  Childhood onset tubular aggregate myopathy associated with de novo STIM1 mutations.

Authors:  Carola Hedberg; Marcello Niceta; Fabiana Fattori; Björn Lindvall; Andrea Ciolfi; Adele D'Amico; Giorgio Tasca; Stefania Petrini; Mar Tulinius; Marco Tartaglia; Anders Oldfors; Enrico Bertini
Journal:  J Neurol       Date:  2014-02-26       Impact factor: 4.849

3.  Stormorken Syndrome Caused by a p.R304W STIM1 Mutation: The First Italian Patient and a Review of the Literature.

Authors:  Oscar Borsani; Daniela Piga; Stefania Costa; Alessandra Govoni; Francesca Magri; Andrea Artoni; Claudia M Cinnante; Gigliola Fagiolari; Patrizia Ciscato; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  Front Neurol       Date:  2018-10-15       Impact factor: 4.003

4.  Peroxisome proliferator-activated receptor γ coactivator 1α regulates mitochondrial calcium homeostasis, sarcoplasmic reticulum stress, and cell death to mitigate skeletal muscle aging.

Authors:  Jonathan F Gill; Julien Delezie; Gesa Santos; Shawn McGuirk; Svenia Schnyder; Stephan Frank; Martin Rausch; Julie St-Pierre; Christoph Handschin
Journal:  Aging Cell       Date:  2019-07-10       Impact factor: 9.304

5.  Chronic inhibition of the mitochondrial ATP synthase in skeletal muscle triggers sarcoplasmic reticulum distress and tubular aggregates.

Authors:  Cristina Sánchez-González; Juan Cruz Herrero Martín; Beñat Salegi Ansa; Cristina Núñez de Arenas; Brina Stančič; Marta P Pereira; Laura Contreras; José M Cuezva; Laura Formentini
Journal:  Cell Death Dis       Date:  2022-06-22       Impact factor: 9.685

6.  Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1.

Authors:  Giorgio Tasca; Adele D'Amico; Mauro Monforte; Aleksandra Nadaj-Pakleza; Marc Vialle; Fabiana Fattori; John Vissing; Enzo Ricci; Enrico Bertini
Journal:  Neuromuscul Disord       Date:  2015-07-17       Impact factor: 4.296

7.  Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patients.

Authors:  Joery P Molenaar; Jamie I Verhoeven; Richard J Rodenburg; Erik J Kamsteeg; Corrie E Erasmus; Savine Vicart; Anthony Behin; Guillaume Bassez; Armelle Magot; Yann Péréon; Barbara W Brandom; Valeria Guglielmi; Gaetano Vattemi; Frédéric Chevessier; Jean Mathieu; Jérôme Franques; Karen Suetterlin; Michael G Hanna; Lucie Guyant-Marechal; Marc M Snoeck; Mark E Roberts; Thierry Kuntzer; Roberto Fernandez-Torron; Amaia Martínez-Arroyo; Juergen Seeger; Benno Kusters; Susan Treves; Baziel G van Engelen; Bruno Eymard; Nicol C Voermans; Damien Sternberg
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.